These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 38574614)

  • 1. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension.
    Chen X; Yu X; Lian G; Tang H; Yan Y; Gao G; Huang B; Luo L; Xie L
    Biomed Pharmacother; 2024 May; 174():116505. PubMed ID: 38574614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension.
    Yamamura A; Fujiwara M; Kawade A; Amano T; Hossain A; Nayeem MJ; Kondo R; Suzuki Y; Inoue Y; Hayashi H; Suzuki S; Sato M; Yamamura H
    Eur J Pharmacol; 2024 Jun; 973():176564. PubMed ID: 38614383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel PDGFR inhibitor WQ-C-401 prevents pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension.
    Huang W; Zhou H; He Y; Wang A; Wang B; Chen Y; Liu C; Wang H; Xie W; Kong H
    Exp Cell Res; 2024 Aug; 441(1):114154. PubMed ID: 38996959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aloperine protects pulmonary hypertension via triggering PPARγ signaling and inhibiting calcium regulatory pathway in pulmonary arterial smooth muscle cells.
    Shan X; Gegentuya ; Wang J; Feng H; Zhang Z; Zheng Q; Zhang Q; Yang K; Wang J; Xu L
    Am J Physiol Cell Physiol; 2023 Oct; 325(4):C1058-C1072. PubMed ID: 37661916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation.
    Zhang Y; Cui Y; Deng W; Wang H; Qin W; Huang C; Li C; Zhang J; Guo Y; Wu D; Guo H
    Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):362-370. PubMed ID: 27873355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective mechanism of sevoflurane in pulmonary arterial hypertension via downregulation of TRAF6.
    Wang G; Wang C; Zhu P; Tian J; Yang H
    Toxicol Appl Pharmacol; 2024 Oct; 491():117065. PubMed ID: 39127353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
    Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
    Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. eIF2α promotes vascular remodeling via autophagy in monocrotaline-induced pulmonary arterial hypertension rats.
    Guo L; Li Y; Tian Y; Gong S; Chen X; Peng T; Wang A; Jiang Z
    Drug Des Devel Ther; 2019; 13():2799-2809. PubMed ID: 31496656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension.
    Zhuang W; Lian G; Huang B; Du A; Gong J; Xiao G; Xu C; Wang H; Xie L
    Mol Cell Biochem; 2019 May; 455(1-2):169-183. PubMed ID: 30511343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aminoimidazole-4-carboxamide ribonucleotide formyltransferase/inosine monophosphate cyclohydrolase promotes pulmonary arterial smooth muscle cell proliferation via the Ras signaling pathway.
    Shi X; Ma Q; Huo Y; Su Y
    Am J Physiol Cell Physiol; 2024 Oct; 327(4):C901-C912. PubMed ID: 39129491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin regulates pulmonary vascular remodeling in pulmonary hypertension by downregulating TGF-β1-Smad2/3 pathway.
    Gao RJ; Aikeremu N; Cao N; Chen C; Ma KT; Li L; Zhang AM; Si JQ
    BMC Cardiovasc Disord; 2024 Oct; 24(1):535. PubMed ID: 39367342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
    He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
    Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canagliflozin ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting pulmonary arterial smooth muscle cell proliferation.
    Tang L; Cai Q; Wang X; Li X; Li X; Chen L; Yang Y
    Clin Exp Hypertens; 2023 Dec; 45(1):2278205. PubMed ID: 37970663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel roles of YULINK in the migration, proliferation and glycolysis of pulmonary arterial smooth muscle cells: implications for pulmonary arterial hypertension.
    Wu YC; Wang WT; Yang MC; Su YT; Yeh JL; Hsu JH; Wu JR
    Biol Res; 2023 Dec; 56(1):66. PubMed ID: 38057829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination treatment of adipose-derived stem cells and adiponectin attenuates pulmonary arterial hypertension in rats by inhibiting pulmonary arterial smooth muscle cell proliferation and regulating the AMPK/BMP/Smad pathway.
    Luo L; Zheng W; Lian G; Chen H; Li L; Xu C; Xie L
    Int J Mol Med; 2018 Jan; 41(1):51-60. PubMed ID: 29115380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
    Cheng Y; Yu M; Xu J; He M; Wang H; Kong H; Xie W
    BMC Pulm Med; 2018 Aug; 18(1):130. PubMed ID: 30086741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MFN2-dependent mitochondrial dysfunction contributes to Relm-β-induced pulmonary arterial hypertension via USP18/Twist1/miR-214 pathway.
    Wang Y; Han D; Chai L; Qiu Y; Liu J; Li D; Zhang Q; Shen N; Chen Y; Chen H; Zhang J; Wang Q; Wang J; Li S; Xie X; Li M
    Eur J Pharmacol; 2024 Oct; 980():176828. PubMed ID: 39094924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGF/MEK/ERK axis represses Ca
    Deng L; Chen J; Wang T; Chen B; Yang L; Liao J; Chen Y; Wang J; Tang H; Yi J; Kang K; Li L; Gou D
    Am J Physiol Cell Physiol; 2021 Jan; 320(1):C66-C79. PubMed ID: 32966125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of Angiomotin-Like 2 Ameliorates Experimental Pulmonary Arterial Hypertension by Inactivating YAP1 Signaling.
    Deng J; Yang G; Zhong N; Liang L; Chen H
    J Cardiovasc Pharmacol; 2024 Sep; 84(3):356-369. PubMed ID: 39027975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
    Cao YY; Ba HX; Li Y; Tang SY; Luo ZQ; Li XH
    Life Sci; 2020 Jun; 250():117548. PubMed ID: 32173312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.